June 20, 2018

These New Findings Support Benefits of Elucida’s C-Dot Technology and Pave the Way for Applications in Medicine, Catalysis, Energy, Optics and Other Areas

NEW YORKJune 20, 2018 /PRNewswire/ — Elucida Oncology, a biotechnology company developing a first-in-class nanotechnology platform, announced that researchers from Cornell University, some of whom are currently working with the company, have published a study in Nature outlining the artificial intelligence-facilitated discovery of an ultra-small synthetic silica nanoparticle with cage structure (‘silicage’). The research offers insights that could enhance the current success of C-Dots, a cancer-targeting particle platform for the detection, real-time visualization, and treatment of cancer, and gain a better understanding of particle formation mechanisms. The research represents the first time that single-particle 3D reconstruction using machine-learning algorithms is applied to inorganic synthetic materials. Results offer important insights that could lead to the development of a wide-range of materials solutions to medical problems but also to other application fields.


Nature Study Leverages Artificial Intelligence to Reveal Never-before-seen Cage Structure of Ultra-small Particles